Clorazepate Oral Suspension (Anhydrous)

How to Give Anhydrous Oral Suspension

Oral Suspension (Anhydrous) is a liquid medication that does not contain water in its base. This might be an oil-based or other special base to help stabilize the medicine. It will look like a regular liquid medication, but often needs a good shake because the drug can settle. Here's how to give it:

1. Shake well each time to mix the medication (5-10 seconds).
2. Measure the dose using the syringe/dropper provided or one recommended by your vet. Insert the top of the oral syringe into the bottle adapter. Turn the bottle upside down and pull the plunger until the medicine reaches the volume required
3. Hold your pet steady: a towel or helper can assist with squirmy pets.
4. Administer the dose slowly into the side of the mouth. Allow small pauses if needed for swallowing.
5. Raise the head slightly to help the medication go down and clean any spills with a little water or tissue.
6. Praise your pet and offer a treat or water (unless advised against feeding right after).
7. Clean the syringe with water immediately after use. Store the bottle as directed, out of sunlight.
8. Consistency is key: Shake each time, measure accurately, and contact your vet if any issues arise.

The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.

Clorazepate is a benzodiazepine derivative utilized in veterinary medicine for the management of neurological and behavioral challenges. It is a prescription medication available for use in dogs and cats, frequently considered by veterinarians in the context of adjunct management for seizure activity or acute situational anxiety. At a pharmacological level, clorazepate acts as a prodrug that is converted in the stomach to its active metabolite, nordiazepam. This active form enhances the activity of gamma-aminobutyric acid (GABA) by binding to specific benzodiazepine receptors within the central nervous system. This mechanism increases the inhibitory influence of GABA on neuronal excitability, providing a method for managing the excessive electrical signaling associated with seizures and heightened arousal states. Your veterinarian will determine the clinical appropriateness of clorazepate based on your pet’s physical signs and diagnostic history.

Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.

Commonly observed effects following the administration of clorazepate include sedation, temporary coordination shifts or a noticeable increase in appetite. Some animals may exhibit paradoxical excitement or irritability rather than the intended calming effect. In feline patients, benzodiazepines are associated with localized hepatic concerns, so your veterinarian will monitor liver values closely if long-term use is discussed. Owners should monitor their pet for any unusual behavioral shifts or significant changes in energy levels and contact their veterinarian promptly with any concerns. This medication is typically used with extra caution or avoided in patients with known severe hepatic or renal impairment. It is also carefully evaluated in pets with a known hypersensitivity to benzodiazepines. Significant interactions can occur if clorazepate is administered concurrently with other central nervous system depressants or specific medications that influence liver enzyme activity. Sudden discontinuation can lead to withdrawal signs, so a structured tapering schedule is essential. Your veterinarian is the right person to provide guidance on the necessary duration of use to ensure the management approach remains suitable for your pet’s individual health status.